Trump's FDA announces radical change to Covid vaccine schedule that will affect millions
The agency says it is now set to only recommend Covid vaccines to older adults over 65 and people who are immunocompromised.
It marks a major shift from the current policy, recommending a dose of the updated Covid vaccine to everyone aged six months and over.
And it could leave millions unable to get the vaccine through their health insurance.
But the FDA head Dr Marty Makary says the change is needed, adding that there is no clear benefit from vaccinating millions of healthy people against Covid every year.
He says it has fostered public distrust and led many to forgo vital vaccinations, such as that against measles — with the US recording its biggest outbreak in two decades this year.
The new policy was revealed in an editorial published Tuesday in the New England Journal of Medicine, authored by Dr Makary and the FDA's head on vaccines Dr Vinay Prasad.
It is set to be unveiled at a press conference later today, and will likely affect people seeking an updated Covid shot in fall 2025.
They wrote: 'Over the past two seasons, uptake of the annual Covid booster has been poor. Less than 25 percent of Americans received boosters each year.
'There may even be a ripple effect: Public trust in vaccination in general has declined, resulting in a reluctance to vaccinate that is affecting even vital immunization programs such as that for measles-mumps-rubella vaccination.'
The change will more closely align the US with other nations, like the UK, Canada and Australia — which all only recommend updated Covid shots to older adults.
Uptake of the updated Covid vaccinations has been in free-fall, with latest CDC data showing barely 20 percent of adults received the shot this respiratory virus season.
The pair added: 'While all other high-income nations confine vaccine recommendations to older adults (typically those older than 65 years of age), or those at high risk for severe Covid...
'... the US adopted a one-size-fits-all regulatory framework and has granted broad marketing authoritzation to all Americans over the age of six months.'
'The US policy has sometimes been justified by arguing that the American people are not sophisticated enough to understand age- and risk-based recommendations.
'We reject this view.'
The pair said Covid vaccines for young adults would be approved, but only after pharmaceutical companies could demonstrate that they create protective antibody concentrations in the group.
Dr Noel Brewer, a public health expert at the University of North Carolina, Chapel Hill, and who sits on the CDC's vaccine recommendation committee, told CNN that he supported the change.
'The proposed policy moves the US into line with other countries. This global view of public health is a welcome development,' he said.
Dr Paul Offit, a pediatrician at the Children's Hospital of Philadelphia and a member of the FDA's vaccines advisory group, disagreed, however.
He said: 'We have been using an evidence-based approach to Covid vaccination, but they kind of swoop in and believe that for the first time, we're going to get, as they say, "gold standard" data, robust data, for the first time, because, according to them, we don't have that, but we do have that.
'That's why we've made good decisions about the vaccines. That's why that vaccine is remarkably safe. I mean, the mRNA vaccines are remarkably safe.'
The FDA is set to announce the policy in a press conference at 1pm today.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Guardian
2 hours ago
- The Guardian
Vinay Prasad returns to FDA days after leaving under pressure from Laura Loomer
Vinay Prasad is returning to his role overseeing vaccine, gene therapy and blood product regulation at the US Food and Drug Administration (FDA) a little more than a week after he left the agency. 'At the FDA's request, Dr Vinay Prasad is resuming leadership of the Center for Biologics Evaluation and Research,' Department Health and Human Services spokesperson Andrew Nixon said in a statement to Reuters. Prasad left the agency on 30 July after just a few months as director of the center. Endpoints News, which covers the biotech industry, first reported the return of Prasad. Prasad, an oncologist who was a fierce critic of US Covid-19 vaccine and mask mandates, was named the center's director by the FDA's commissioner, Marty Makary, in May. Criticism of Prasad's tenure intensified around the agency's handling of a gene therapy for Duchenne muscular dystrophy (DMD) from Sarepta Therapeutics. The FDA-approved therapy played a role in the death of two teens who had advanced DMD. After a third death in a separate experimental gene therapy from the company, the FDA asked Sarepta on 18 July to stop all shipments of the approved DMD therapy, saying it had safety concerns. The FDA changed course on Sarepta on 28 July and said shipments to the main group of patients for the drug could restart. Laura Loomer, a far-right influencer and conspiracy theorist with outsized sway over Donald Trump, had called Prasad a 'progressive leftist saboteur' who was undermining the agency's work. Two days before Prasad stepped down last month, Loomer had released misleadingly edited audio to suggest that that Prasad had admitted sticking pins in a Trump voodoo doll, when the full audio made it clear that he was talking about the kind of thing an imagined liberal Trump-hater would do. Loomer reacted to the news of Prasad's return on Saturday by renewing her attacks on him in a social media post in which she promised to produce 'exposes of officials within HHS and FDA' in the weeks ahead. 'There are several Senate Confirmation hearings coming up and I have multiple oppo books ready for distribution!' she wrote. Prasad was a physician who joined the agency from the University of California, San Francisco. He has had stints at the National Cancer Institute and the National Institutes of Health. The FDA and other health agencies have seen multiple shake-ups in recent months under the leadership of health secretary Robert F Kennedy Jr.
The Guardian
4 hours ago
- The Guardian
Vinay Prasad returns to FDA days after leaving under pressure from Laura Loomer
Vinay Prasad is returning to his role overseeing vaccine, gene therapy and blood product regulation at the US Food and Drug Administration (FDA) a little more than a week after he left the agency. 'At the FDA's request, Dr Vinay Prasad is resuming leadership of the Center for Biologics Evaluation and Research,' Department Health and Human Services spokesperson Andrew Nixon said in a statement to Reuters. Prasad left the agency on 30 July after just a few months as director of the center. Stat News first reported the return of Prasad. Prasad, an oncologist who was a fierce critic of US Covid-19 vaccine and mask mandates, was named the center's director by the FDA's commissioner, Marty Makary, in May. Criticism of Prasad's tenure intensified around the agency's handling of a gene therapy for Duchenne muscular dystrophy (DMD) from Sarepta Therapeutics. The FDA-approved therapy played a role in the death of two teens who had advanced DMD. After a third death in a separate experimental gene therapy from the company, the FDA asked Sarepta on 18 July to stop all shipments of the approved DMD therapy, saying it had safety concerns. The FDA changed course on Sarepta on 28 July and said shipments to the main group of patients for the drug could restart. Laura Loomer, a far-right influencer and conspiracy theorist with outsized sway over Donald Trump, had called Prasad a 'progressive leftist saboteur' who was undermining the agency's work. Two days before Prasad stepped down last month, Loomer had released misleadingly edited audio to suggest that that Prasad had admitted sticking pins in a Trump voodoo doll, when the full audio made it clear that he was talking about the kind of thing an imagined liberal Trump-hater would do. Loomer reacted to the news of Prasad's return on Saturday by renewing her attacks on him in a social media post in which she promised to produce 'exposes of officials within HHS and FDA' in the weeks ahead. 'There are several Senate Confirmation hearings coming up and I have multiple oppo books ready for distribution!' she wrote. Prasad was a physician who joined the agency from the University of California, San Francisco. He has had stints at the National Cancer Institute and the National Institutes of Health. The FDA and other health agencies have seen multiple shake-ups in recent months under the leadership of health secretary Robert F Kennedy Jr.
The Sun
4 hours ago
- The Sun
I thought pregnancy would leave me glowing but I ended up unrecognisable – my face left me in tears
A WOMAN has revealed the dramatic change she underwent during pregnancy, with her face looking completely unrecognisable. Farah Faizal (@ayyitslala) thought she was going to look glowing during her pregnancy, but ended up crying over her changing appearance. 2 2 In a viral video, that has racked up 116 million views, Farah shared some snaps of herself before she was pregnant. The brunette beauty looks stunning, with clear skin and gorgeous features. However, she then shared a number of clips of how she looked during her pregnancy, and she is completely unrecognisable. Her nose had almost tripled in size, and her face was extremely red and swollen. "Survived nine months of chaos, cried over my face more than I'd like to admit, and now I'm officially someone's mum", she said. "Healing in progress…" Sharing a snap of herself one month after giving birth, Farah's skin looks a lot less red and swollen, and her nose is beginning to shrink in size. She revealed that she went to the doctor about her condition and has been healing herself with creams and laser treatment. Thankfully, Farah revealed that her husband was extremely supportive during her pregnancy, and helped her through every "breakdown". "He constantly reminded me that I was beautiful strong and loved", she said. I thought I was glowing in my pregnancy until my NOSE popped at week 25 - people say it looks like I've used a filter More than 40% of women experience acne during pregnancy, which is caused by hormonal changes. Many women also experience their noses growing in size. "Although 'pregnancy nose' is not a medical term, many women's noses do appear to be bigger toward the end of pregnancy, and they may also experience more frequent nasal drainage than prior to pregnancy," says Jessica Madden, M.D., IBCLC, a board-certified neonatologist, pediatrician, lactation consultant, and the medical director of Aeroflow Breastpumps. How to reduce pregnancy nose Face yoga instructor Angela Rosoff has revealed her free techinque to reduce the size of your nose during pregnancy. She starts with cleansing her face before applying a "light facial oil or serum." Next, she gets into position by pressing her index fingers on either side of her nose. "Start the compression," she said. "Place your fingers at the base of your nose, near the nostrils. "Compress and release. Gently press the sides of your nose together and hold for two to three seconds, then release." She then repeats the process 10 to 15 times, finishing off by massaging around the nose in soft, circular motions.
